Brain Tumors in Children
Author:
- 19 May 2022
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 386 (20) , 1922-1931
Abstract
Childhood brain tumors were previously classified by histologic appearance and location. A new classification includes genetic changes, which have prognostic significance and may lead to therapeutic targets. This review focuses on pediatric gliomas, ependymomas, and medulloblastomas.Keywords
This publication has 70 references indexed in Scilit:
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapyExpert Opinion on Therapeutic Targets, 2012
- MAPK pathway activation in pilocytic astrocytomaCellular and Molecular Life Sciences, 2011
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupNeuro-Oncology, 2011
- Survival and long-term health and cognitive outcomes after low-grade gliomaNeuro-Oncology, 2010
- Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic AstrocytomasCancer Research, 2008
- BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasJournal of Clinical Investigation, 2008
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumorsCancer, 2007
- Temozolomide in Children with progressive low-grade glioma1Neuro-Oncology, 2007
- Medulloblastoma: Clinical and biologic aspectsNeuro-Oncology, 1999